API Oration, Varanasi, January 2003 Improved glycemic control reduces microvascular complications in both type 1 and type 2 diabetes. Macrovascular complications predominate in type 2 diabetes, and the effect of tight control here is less clear. Treatment of other aspects of insulin resistance (BP, lipids) significantly reduces cardiovascular morbidity and mortality in type 2 diabetes. Insulin therapy has favorable effects on endothelial function and lipids, especially compared with sulfonylureas. More information is needed on the effects of diabetes pharmacotherapy on cardiovascular outcomes.
|Original language||English (US)|
|Number of pages||5|
|Journal||Journal of Association of Physicians of India|
|State||Published - May 1 2003|
ASJC Scopus subject areas